Complementary DNA encoding the human CYR61 protein was isolated from human embryonic tissues and mapped to chromosome 1p22-p31. We show that CYR61 encodes a 381 amino acid protein rich in cysteine and proline residues that is strongly conserved with the mouse homologue. Sequence analysis reveals the presence of several distinct protein domains which confer a mosaic structure to this protein and makes human CYR61 a member of a recently described growth regulator family that includes several proto-oncogene products. From our results we hypothesize that this new immediate early gene may play a role in cell commitment during embryogenesis and more generally in the control of cell proliferation.
Characterization of genes controlling cell growth and dierentiation during embryogenesis or of genes encoding potential tumor suppressor proteins that inhibit cell proliferation in favor of cell dierentiation is obviously fundamental in order to understand the molecular basis of development and oncogenesis. Cell stimulation by diverse growth factors as well as by transforming oncogenes commits the cell to a complex genetic program. Very rapidly during this program a set of genes, usually termed immediate early genes, have been shown to be transcriptionally activated in response to stimulation (Herschman, 1991) . This transcriptional activity which takes place within minutes after stimulation does not require de novo protein synthesis. We focused on this family of genes assuming that their characterization will be helpful in order to further the understanding of some of the cellular signal transduction pathways activated following stimulation of the cell by growth factors, or throughout cell determination/dierentiation processes occurring during human embryogenesis. We cloned several of these genes by screening a human embryo cDNA library and selecting low abundance cDNAs, instead of the diverse subtractive or dierential hybridization approaches used in many research teams (Lau and Nathans, 1985; Simmons et al., 1989) . Immediate early genes that have been identi®ed to date can be grouped together according to their respective well known or putative functions. Some of them for example encode transcriptional regulators (jun, fos, myc, fra-1, SRF, krox 20/egr-2, egr-1/TIS8), whilst other immediate early genes encode proteins involved in paracrine intercellular communication (such as cytokines), in cytoskeleton or in extracellular matrix. In the latter group, several highly related proteins have been recently characterized using dierent approaches and diverse models. Cef10 is the ®rst gene of this group to have been described after it was cloned from chicken embryonic ®broblasts upon induction by the viral oncogene pp60 v-src (Simmons et al., 1989) . Later, a close relative, Cyr61 (also called bIG-M1), was cloned among a set of immediate early genes rapidly induced by serum, by puri®ed plateletderived growth factor or by TGF-b1 in mouse ®broblasts (O'Brien et al., 1990; Brunner et al., 1991) . A third member, CTGF (Connective Tissue Growth Factor gene), was detected both by screening a human umbilical vein endothelial cell cDNA library with anti-PDGF antibodies (Bradham et al., 1991) and in human foreskin ®broblasts under TGF-b stimulation (Igarashi et al., 1993) . The mouse orthologue was termed ®sp-12 and was also shown to be induced by serum (Ryseck et al., 1991) . Finally, a chicken gene, nov, normally arrested in adult kidney was shown to be overexpressed in myeloblastosis-associated virus type 1-induced nephroblastomas (Joliot et al., 1992) . Its human orthologue, novH, was also identi®ed and was found to be associated with dierent human tumors such as Wilm's tumor as suggested by its chromosomal localization . Finally the Xenopus laevis nov gene has recently been cloned (Ying and King, 1996) . The emergence of this family of growth regulators led Bork to propose to group these genes under the denomination`CCN family' (for CTFG, Cef10/Cyr61, nov family) (Bork, 1993) . In this communication we report the isolation from an embryonic source of a cDNA encoding the complete sequence of the human CYR61 protein, its conservation with the other members of the CCN family, primary analysis of its expression pattern in human tissues as well as its mapping to chromosome 1p22-31.
Screening of 4610 3 clones from a 6 week-old human embryo cDNA library with a probe derived from the same cDNA mixture that was used to construct the library allowed us to isolate low abundance cDNAs that were systematically partially sequenced (Jay et al. in press ). The partial nucleotide sequence of clone HE6WCR113 revealed signi®cant homology with mouse Cyr61 mRNA and the HE6WCR113 sequence was subsequently completed. This cDNA is 2014 nucleotides long, including a polyadenylation signal but excluding the poly(A) + tail ( Figure 1 ). The nucleotide sequence of the 3' untranslated region is very well conserved when compared to that of mouse, especially in its second half where AU-rich elements are perfectly identical (not shown). The mRNA instability conferred by these AU sequences is now well documented and is one of the mechanisms known to increase the rate of mRNA degradation (Shaw and Kamen, 1986) . AU elements are present in numerous mRNAs encoding secreted growth factors or other transiently expressed genes. The predicted translation product is a 382 amino acid polypeptide with a calculated molecular weight of about 42 kDa and with a calculated isoelectric point of 8.06. The dierent features which helped to characterize CYR61 protein are shared by the other members of the CCN family. Human CYR61 is particularly cysteine-rich (10% of all residues) and displays a remarkable degree of evolutionary conservation (92.8% identity with the equivalent mouse gene product) ( Figure 2 ). The conserved cysteines are clustered in two segments and are totally absent from the central acidic domain of the protein which is furthermore highly variable when compared with that of other members of the CCN family ( Figure 2 ). Twenty-®ve prolines are scattered throughout much of the CYR61 protein and most probably prevent a-helix formation. CCN family members were de®ned as proteins with a mosaic structure because they all contain several motifs shared by various functionally unrelated proteins (Bork, 1993) . These domains are strongly conserved in the human CYR61 gene product (Figure 2) . From the N-to the C-terminal part of the human CYR61 protein, the ®rst striking feature is the presence of a hydrophobic N-terminal stretch of 24 residues with a predicted a-helix structure in good agreement with the function of a signal peptide which probably directs CYR61 to the secretory pathway for subsequent export (Gorr and Darling, 1995) . The ability of the mouse homologue to be secreted was con®rmed by its association with both the extracellular matrix and the cell surface where it may act as a cell adhesion molecule (Yang and Lau, 1991) . It is worth noting that these properties (export, protein localization, high cysteine content) are also shared with the protooncogene product Int-1/Wnt-1 (Brown et al., 1987) . A second important feature is the sequence of GCGCCKVC which begins at residue 49 ( Figure 1 ) and conforms to the GCGCCXXC motif found in insulin-like growth factor binding proteins (Kiefer et al., 1991) . It remains to be established if this cysteinerich domain really acts as a growth factor binding domain. It is however noteworthy that in the case of nov, an amino-terminal-truncated variant deleted for Figure 1 Nucleotide sequence and predicted amino acid sequence of the human CYR61 cDNA. The amino acid sequence is presented in the single-letter code under the ®rst position of the corresponding codons. The GenBank accession number for this sequence is U62015. Cysteine residues are encircled. The ®rst in-frame stop codon is indicated by an asterisk. A consensus polyadenylation signal in the 3' non coding region at position 1996-2001 is boxed. AU-rich elements are underlined. For molecular cloning of human CYR61 cDNA, total RNA was extracted from 6 week-old embryos following the method of Chomczynski and Sacchi. Poly(A) + mRNAs were isolated by one cycle of binding elution on oligo(dT)-cellulose. Five micrograms of poly(A) + RNA served as template in the preparation of size fractionated (4400 basepairs) cDNAs using the lZAP-cDNA synthesis kit (Stratagene, La Jolla, California). Around 4000 clones were screened using the original cDNA mixture as a probe after labeling with a random priming kit (Megaprime, Amersham). The same ®lter was then rehybridized with a vector-speci®c probe to detect all the clones present. Over 250 clones were not detected with the cDNA probe and were subsequently considered as low abundance cDNAs. The 3' ends of these clones were systematically sequenced using double stranded sequencing strategy with Taq DyeDeoxyTerminator kit and an Applied Biosystems 373A automated DNA sequencer (Foster City, California). Sequences were analysed and examined for homology using the Winconsin Genetics Computer Group (GCG) programs and ®tted together with GAP function from this program package
The human CYR61 cDNA P Jay et al this motif is sucient to induce ®broblast transformation (Joliot et al., 1992) . The third domain (VWC domain, Figure 2 ) was originally found as a repeat in the large multifunctional Von Willebrand factor protein, but is also present in several mucins where it may contribute to form oligomers (Bork, 1993) . Finally, the last two cysteine-rich regions, termed TSP1 and CT domains ( Figure 2 ) were postulated to be involved in the binding of both soluble and matrix molecules such as sulphate glycoconjugates in cell adhesion. These domains are also partially shared by a family of mucin-like proteins and by the recently cloned Norrie disease gene (Chen et al., 1993) . Tissue distribution of the human CYR61 mRNA was determined by Northern blotting (Figure 3 ). It revealed a rather wide expression of CYR61 mRNA in adult as well as in fetal human tissues and the level of expression varied largely between the tissues tested. Human CYR61 expression was not detected in leukocytes (not shown), whilst moderate amounts of messenger were found in fetal or adult brain and liver, adult lung, adult kidney and adult thymus. The pattern of expression that we obtained con®rms previous data from mouse which shows that expression of CYR61 mRNA is not speci®c to one particular tissue but rather distributed in several organs (O'Brien et al., 1990) . The tissue distribution reported by O'Brien et al. is partially divergent from the one that we describe in this study but several factors explain this discrepancy. First, the methods used in both studies are dierent since O'Brien et al. used RNAse protection instead of Northern blotting in our case. Second, as can be seen in Figure 3 , the level of expression of Cyr61 mRNA can dier signi®cantly between fetal and adult tissues (in kidney for instance) and the use of samples that do not originate from the same developmental stage may therefore also contribute to the dierence in CYR61 mRNA expression. Finally, interspeci®c dierences between orthologous gene expression patterns can also occur and do not presume dierent functions since in any case, the presence of the messenger does not necessarily imply that of the functional corresponding protein.
On the other hand, cloning of human CYR61 from an 6 week-old embryonic cDNA library was enabled by the early expression of this gene during embryogenesis, consistent with previous data in mouse describing the expression of Cyr61 in midgestation embryos, and essentially correlated with the developing cartilaginous structures and circulatory system (O'Brien and Lau, 1992) . It is therefore likely that CYR61 also contributes to such cell commitment events during early human development as is suggested by distantly related genes like twisted gastrulation in Drosophila (Mason et al., 1994) . Two distinct mRNAs were detected with the CYR61 probe, a major one at 2.5 kb and a minor one at about 4 kb. Since the relative amount of both mRNAs is similar among the dierent tissues tested, it is likely that they represent transcripts from the same locus that were dierentially spliced or that used dierent polyadenylation signals. Another possibility is that the two transcripts represent dierent members of the CCN family but this is rather unlikely since only one signal was detected by¯uoresence in situ hybridization (FISH) analysis.
The human CYR61 gene was mapped to chromosome 1 at position p22-p31 by¯uorescence in situ hybridization (Figure 4) . Screening of genetic databases revealed the possible location on chromosome 1 of a locus with a malignant transformation suppression activity (Stoler and Bouck, 1985) . Because of syntheny with mouse chromosome 4, the locus identi®ed by Stodler and Bouck is likely to map on 1p, distal to 1p22.1 (Zabel et al., 1985) . More recently, abnormalities of chromosome 1p were also shown to correlate with breast cancer (Hainsworth et al., 1992) , neuroblastoma (Gehring et al., 1995) , pheochromocytoma (Shin et al., 1993) or even with primary hepatomas (Simon et al., 1991) . Besides this chromosomal localization diverse characteristics previously reported for the mouse homologue contribute in making CYR61 an attractive candidate for a proto-oncogene. Due to the very high level of sequence similarity among the members of the CCN family, these secretory proteins, including a putative oncoprotein as well as a connective tissue growth factor probably share most of their molecular functions. Transcriptional induction of mouse Cyr61 was obtained via diverse stimuli, including serum, PDGF, FGF, TPA, oncogene v-src (O'Brien et al., 1990) , ionomycin (Sells et al., 1994) or even during liver regeneration following partial hepatectomy (Nathans et al., 1988) . Mouse Cyr61 was shown to be a secreted protein with the ability to interact with both cell surface and extracellular matrix but also with heparin (Yang and Lau, 1991) , and its primary structure also revealed its putative growth factor binding capacity. Taken together, these properties suggest a role for Cyr61 in cell-cell and cellextracellular matrix interactions acting as a mediator in the growth response and subsequently in the control of cell proliferation. Further analysis of the human CYR61 gene sequence and localization will be very helpful in order to determine whether an alteration of CYR61 sequence or expression is associated with malignancy. Figure 4 Fluorescence in situ hybridization on R-banded chromosome using the full length CYR61 cDNA. Chromosome metaphases were obtained from phytohemagglutinin-stimulated blood lymphocytes of a healthy donor after thymidine synchronization and bromodeoxyuridine incorporation (ViegasPequignot and Dutrillaux, 1978) . The probe was labeled with biotin-16 dUTP by random priming. In situ hybridization was performed according to Pinkel et al. (1986) . After one ampli®cation, R bands were obtained as described (Lemieux et al., 1992) . Idiogram of chromosome 1 showing the distribution of uorescent spots on the 1p22-p31 bands for the 10 most resolutive metaphases
